Capnography Devices Market Size

Capnography Devices Market Size

Capnography Devices Market size surpassed USD 520 million in 2020 and is estimated to grow at a CAGR of over 7.4% between 2021 and 2027. Rising prevalence of respiratory disorders has led to an upsurge in surgical interventions, thereby propelling the demand for capnography devices to confirm that the pulmonary circulation is unobstructed and to observe the changes of end-tidal carbon dioxide pressure. The use of these devices offers better patient compliance as well as aids in monitoring patients during general anaesthesia.

To get key market trends

  Download Free Sample

Capnography devices have emerged as a preferred choice in the monitoring of malignant airway lesions due to satisfactory clinical outcomes. Growing conscience among the people suffering from central airway obstruction, chronic obstructive pulmonary disease (COPD), lung cancer, and asthma regarding the availability of minimally invasive procedures with lowered adverse effects is boosting the acceptance of effective and non-invasive methods of monitoring called capnography.

However, a lack of skilled professionals with technical expertise to use capnography instruments may have a negating impact on the market growth. Capnography devices are complex in nature and thus need trained operators to handle them. Shortage of skilled staff, specifically in developing nations may limit the use of these devices. Furthermore, the high cost associated with certain capnography devices may further obstruct the market expansion. Moreover, the U.S. FDA closely monitors the development of these devices and approves commercialization based on their performance.
 

The emergence of COVID-19 is an unprecedented public health concern and has led to an increased number of hospitalizations. The outbreak of the coronavirus pandemic has infected millions of people across the globe. As per the meta-analysis of seven studies, the researchers concluded that people with severe COPD may have a higher risk of COVID-19 complications as COVID-19 affects the respiratory system. Thus, in early 2020, the unprecedented effect of COVID-19 had a moderate impact on practices for airway management treatments as all the elective procedures across the globe had been postponed.
 

However, with the formulation of policies and standards to assure the safety of the patient, the number of procedures continued to increase again. Thus, in response to COVID-19, the healthcare system is rapidly restructuring practices for airway obstruction to ensure that patients receive essential care while minimizing exposure to COVID-19 infection. Therefore, the market is predicted to experience considerable growth in the coming years with a decreasing number of COVID-19 patients in some regions and beneficial government protocols.